Showing results (41-50 of 173) with videos related to
Sort By:
Pageof 18
Alimentary Pharmacology & Therapeutics|April 27, 2019
Improvement in enhanced liver fibrosis score and liver stiffness measurement reflects lower risk of hepatocellular carcinomaLilian Yan Liang, Vincent Wai-Sun Wong, Yee-Kit Tse, et al.The American Journal of Gastroenterology|October 14, 2018
On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related CirrhosisTerry Cheuk-Fung Yip, Henry Lik-Yuen Chan, Yee-Kit Tse, et al.JHEP Reports : Innovation in Hepatology|June 11, 2025
Impact of cardiometabolic risk factors on hepatic fibrosis and clinical outcomes in MASLD: A population-based multi-cohort studyHuiyul Park, Terry Cheuk-Fung Yip, Eileen L Yoon, et al.Journal of Hepatology|October 28, 2018
HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analoguesTerry Cheuk-Fung Yip, Grace Lai-Hung Wong, Henry Lik-Yuen Chan, et al.Clinical and Translational Gastroenterology|March 22, 2021
Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide AnalogVicki Wing-Ki Hui, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, et al.Hepatology (Baltimore, Md.)|September 5, 2022
Geographical similarity and differences in the burden and genetic predisposition of NAFLDTerry Cheuk-Fung Yip, Eduardo Vilar-Gomez, Salvatore Petta, et al.Journal of Hepatology|October 10, 2017
Durability of hepatitis B surface antigen seroclearance in untreated and nucleos(t)ide analogue-treated patientsTerry Cheuk-Fung Yip, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, et al.Journal of Hepatology|May 15, 2018
Normal on-treatment ALT during antiviral treatment is associated with a lower risk of hepatic events in patients with chronic hepatitis BGrace Lai-Hung Wong, Henry Lik-Yuen Chan, Yee-Kit Tse, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2026
Validated Nationwide Scoring System for Hepatocellular Carcinoma Risk in Metabolic Dysfunction-Associated Steatotic Liver DiseaseTeng-Yu Lee, Sherlot Juan Song, Hsiu J Ho, et al.Journal of Viral Hepatitis|July 3, 2025
Recognisable Alcohol Use Significantly Increases the Risk of Adverse Outcomes in Patients With Hepatitis B Virus-Related CirrhosisVicki Wing-Ki Hui, Zeyuan Yang, Terry Cheuk-Fung Yip, et al.Pageof 18